Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,959.20
(
-0.23%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.67
(
2.41%
)
Bitcoin
73,648.76
(
-1.60%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 63383

Friday, 07/25/2008 4:08:06 AM

Friday, July 25, 2008 4:08:06 AM

Post# of 257250
LLY Formally Terminates Factor Xa Program

> LLY has not stated that it has discontinued development of LY517717…<

It’s now official. From yesterday’s CC:

http://seekingalpha.com/article/86916-eli-lilly-co-q2-2008-earnings-call-transcript?page=2

›“We’ve previously indicated that a toxicology finding had been observed in long-term animal studies with our Factor Xa Inhibitor. After completing a thorough review of the data, we have decided to halt clinical development of this compound.”‹

They still won’t say exactly what the tox problem was.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now